Request a Proposal
Updated City Blocks

Product lifecycle solutions

We deliver intelligent insights through the pharmaceutical product lifecycle

Lifecycle Diagram TM
From early-stage commercial opportunity assessment and market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and post-launch tracking, we can support pharma with intelligent market research and consulting solutions through the lifecycle of the brand.

- Drug opportunity assessment »
- Understanding the global market »
- Developing the product offering »
- Developing a pharmaceutical brand »
- Brand launch and beyond »

We promise:

Senior level involvement

Our large, senior team of over 40 Directors are involved at every stage of the project.

High quality research

Our outputs answer the key business questions with a clear, direct recommendation, supported by the research evidence.

Communication and flexibility

We keep clients informed through weekly updates and respond quickly to needs and deadlines.

A creative approach

We offer custom approaches, not branded solutions, so our research design is always creative and fresh.

Qualitative excellence »

  • Some example case studies
    Qualitative segmentation validation study with backroom brainstorm exercises

    The challengeOur client had an oncology product in development for the treatment of prostate cancer. The company wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms. In an earlier quantitative wave of research we had identified four segments to define physician treatment and prescription behaviors. Our next challenge was to validate the segmentation. Our client wanted to…

    read more »
    Device Attribute Testing

    The challengeOur client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio against their competitors. The patient evaluation needed to reflect real life as much as possible, so that it truly reflected patient preference and could…

    read more »
    Corporate Equity Survey

    The challengeOur client’s senior management wanted to assess its company’s image amongst their key HCP stakeholders. The client wanted to measure familiarity and perceptions of the company versus its competitors, particularly in light of recent corporate announcements. They also wanted to identify opportunities for influencing customer opinion.  The solututionIt was critical for the results to be globally robust, so we conducted online interviews with 1,500…

    read more »
  • Our latest white papers
    Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations

    In this paper we examine the differences between behavioural and attitudinal approaches to segmentation and outline how integration of the two can best be achieved to strengthen segmentation solutions

    read more »
    South Korea: The next global player?

    In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two conflicting global health indicators: longest life expectancy and highest suicide rates.

    read more »
    Will gene therapies finally be commercially viable to pharma?

    Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when attempting to develop this technology. We review gene therapy’s chequered past, look at recent developments in this field and consider the future for gene therapies on their way to market.

    read more »